Bayer reports phase I results for prostate cancer therapy
Go back to Bayer reports phase I results for prostate cancer therapy| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 12.71 +0.02 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.69 | 52 Week High | $135.54 | |||
| Open | $12.47 | 52 Week Low | $94.36 | |||
| Day High | $12.72 | P/E | N/A | |||
| Day Low | $12.47 | EPS | $0.00 | |||
| Volume | 148,322 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 50.56 -0.37 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.93 | 52 Week High | $135.00 | |||
| Open | $50.56 | 52 Week Low | $94.95 | |||
| Day High | $50.56 | P/E | N/A | |||
| Day Low | $50.56 | EPS | $0.00 | |||
| Volume | 749 | |||||



